Skip to main content
Artem ErshovUrologist · Candidate of Medical Sciences

A clinical counterexample · strategy matters more than a template

Stones up to 55 mm — without a single incision

A surgeon's strength lies not only in the ability to operate. It also lies in knowing when to choose rather than surgery, when the evidence points to a safer approach.

01 / The system's verdict

The standard pathway posed an unacceptably high risk for this patient

The patient was 73 years old. Multislice CT revealed bilateral staghorn stones of a critical size:

  • right kidney — up to 40×55 mm, with moderate hydroureteronephrosis;
  • left kidney — up to 30×42 mm;
  • anaesthetic status — ASA IV.

Risk was determined not by age alone, but by severe comorbidity: class III obesity (BMI 41,9), coronary artery disease, post-infarction cardiosclerosis, type 2 diabetes mellitus, COPD and chronic heart failure.

For this stone burden, PCNL is usually the first-line treatment. However, in this case, the surgical and anaesthetic risk of elective PCNL was assessed as extremely high. The alternative was long-term nephrostomy drainage: external tubes, care and regular replacements without addressing the cause.

02 / A strategic crossroads

Three paths. Very different consequences of the decision

Choice of treatment strategy in this clinical case
Care pathwayWhat it offeredThe cost of the decision
Gold standardPercutaneous surgeryDirect removal of large and staghorn stonesExtremely high risk life-threatening perioperative complications
Initial planNephrostomy drainageEnsuring urinary drainageReduced quality of life: the stones remain, and the drains require care and replacement
Selected strategyControlled chemolysisA chance to dissolve suspected uric acid stones without surgeryComplete dissolution in this case — with close monitoring and high treatment adherence

03 / A change of paradigm

One CT parameter changed the entire treatment pathway

On re-evaluation of the multislice CT, stone density was only 350–400 HU, and the initial urine pH was 5,0. Together, these findings strongly suggested a uric acid composition.

This was not conclusive proof. However, the combined CT, radiographic and laboratory findings justified moving away from the standard approach and choosing intensive, closely monitored oral chemolysiswith a citrate mixture.

3D reconstruction of multislice CT showing a marked stone with a density of 350–400 Hounsfield units
Low density was not a diagnosis in itself, but a predictor that had to be considered alongside urine pH and the other findings.

04 / Designing for adherence

A complex regimen was turned into four clear steps

A complex daily regimen in an older patient is more likely to lead to mistakes or treatment discontinuation. The care pathway was therefore designed around this patient's actual limitations.

  1. Digital precision

    Reduced vision made paper strips difficult to read. They were replaced with an electronic pH meter. Fresh urine pH was checked throughout the day and kept within the range prescribed by the doctor 6,8–7,2. Higher does not mean better: excessive alkalinisation increases the risk of other stone types.

  2. Tolerance of the solution

    The well-diluted citrate solution was taken through a straw to reduce contact with the front teeth and aversion to the taste, followed by rinsing the mouth with water. This is a supportive measure, not a guarantee of enamel protection.

  3. Individualised night-time hydration

    A glass of water and the evening dose of medication were taken before bed, with another glass during a usual night-time awakening. This shortened the prolonged acidic urine interval overnight. Because of heart failure, the total volume was not increased without medical advice — only within the individual limit.

  4. Visual tracking

    Each reading within the target range was marked in green on a large wall calendar. Contact with the doctor every two weeks helped maintain the routine and allowed timely adjustments to the regimen.

05 / Outcome after 4 months

Stone-free without surgery

On the follow-up multislice CT dated 19 January 2024 no stones were visible in either kidney, and urine drainage was unobstructed. This was complete dissolution in a single clinical case, not a universal guarantee.

Uric acid
540→230µmol/L · normal blood uric acid
Creatinine
123→109µmol/L
Urea
9,9→7,5mmol/L
Urine pH
5,0→6,8–7,0stable
Before treatment: 3D reconstruction of multislice CT shows bilateral staghorn stones, measuring 40×55 mm on the right and 30×42 mm on the left.
3D reconstruction of multislice CT after four months: no stones are visualised in either kidneyBefore treatmentAfter 4 months
Anonymized 3D reconstructions from a single clinical case, shown in comparable projections. Move the slider with a mouse, a finger or the arrow keys. The medical assessment is based on the complete multislice CT series and the radiologist's report, not on a single image.

Verifiable evidence

Sources

  1. Russian clinical guidelines: UrolithiasisUric acid stone chemolysis, pH monitoring and treatment selection
  2. EAU Guidelines on Urolithiasis, 2026Oral chemolysis and surgical management of large stones
  3. Spettel et al., Urology, 2013CT density and urine pH as predictors of uric acid stone composition